AdjournmentMonday, 29 June 2026

Intergenerational impacts of diethylstilbestrol on mothers and children

End-of-day debate on a single topic

An adjournment debate on the long-term health effects of diethylstilbestrol (DES), a synthetic oestrogen widely prescribed to pregnant women between the 1940s and 1970s before being withdrawn due to serious adverse effects. The debate will examine how DES exposure affected not only the mothers who took the drug but also their children and grandchildren, raising questions about NHS recognition, patient support, and compensation for affected families.

Thousands of British women and their descendants were exposed to DES, which caused cancer, reproductive abnormalities, and other serious illnesses. The debate highlights whether the NHS and government have adequately acknowledged this medical scandal and whether affected patients receive proper care and support. This affects multiple generations and raises broader questions about pharmaceutical safety accountability.

Securing MP

Related business

Upcoming similar business

Past similar business

Upcoming on related topics

Past on related topics